SUBSCRIBE
SUBSCRIBE
News   FDA

Genentech, Inc. (JOBS), OSI Pharmaceuticals, Inc. Warn Of Liver Damage From Tarceva, 2 Deaths

September 23, 2008 | 
1 min read
WASHINGTON (Reuters) - Genentech Inc and OSI Pharmaceuticals have alerted doctors about cases of liver damage among patients who took the cancer drug Tarceva, U.S. regulators said on Tuesday.
FDA Approvals Regulatory
MORE ON THIS TOPIC
halftone magazine style banner, dislike, negative rating, hand thumbs down
FDA
FDA Drops Another Cache of Heavily Redacted Rejection Letters, Promises Future ‘Real-Time’ Access
September 4, 2025
 · 
4 min read
 · 
Annalee Armstrong
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
Regulatory
‘All Wrapper, No Gift’: FDA Releases New Rare Disease Approval Framework
September 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Vaccines
Prasad Demands YouTube Remove Videos Where He Criticized COVID-19 Vaccines
September 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Vaccines
Prasad Signals Steeper Requirements for COVID-19 Vaccines
September 3, 2025
 · 
3 min read
 · 
Tristan Manalac